ProfileGDS5822 / ILMN_2737092
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 71% 77% 73% 77% 76% 73% 76% 74% 75% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 154.271
GSM1276600PDAC Late Ablation Control 210577
GSM1276601PDAC Late Ablation Control 399.573
GSM1276602PDAC Late Ablation 1101.377
GSM1276603PDAC Late Ablation 2103.576
GSM1276604PDAC Late Ablation 379.573
GSM1303940PDAC Late Ablation_anti-CTLA4 184.676
GSM1303941PDAC Late Ablation_anti-CTLA4 2103.774
GSM1303942PDAC Late Ablation_anti-CTLA4 3113.875